ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Result Summary for Survey: Management of Patients with Barrett’s Esophagus and Hign Grade Dysplasia
Barrett’s esophagus is sometimes complicated by high grade dysplasia. This survey was designed to inform readers about current practices in surveillance for and management of this problem. For purposes of this survey, respondents were asked to assume that they were referred a healthy middle aged patient who had been diagnosed with Barrett’s esophagus. The patient had undergone endoscopy by a gastroenterologist showing no evidence for cancer, and reflux symptoms were well controlled on acid suppression therapy.
The number of respondents was low, suggesting that most readers are not actively managing patients with Barrett’s esophagus. Of those responding, the majority are involved in managing such patients. It is widely believed among respondents that antireflux surgery reduces the risk of high grade dysplasia developing in Barrett’s mucosa. All respondents agree on the need for endoscopic surveillance in patients with Barrett’s esophagus. There is considerable disagreement regarding the likelihood of invasive cancer being present when HGD is diagnosed, with more than 50% of respondents believing the risk is 20% or less. Repeat endoscopy and EUS are the most common procedures recommended when HGD is identified. For patients with confirmed HGD, two-thirds of respondents believe esophagectomy is the appropriate therapy, which is in contrast to the fact that most respondents believe the risk of cancer is less than 20%.
1. Do you manage patients with Barrett's esophagus? | |||
---|---|---|---|
answered question | 42 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Yes | 83.3% | 35 | |
No | 16.7% | 7 |
2. Do you believe that fundoplication surgery can help prevent the development of high grade dysplasia in Barrett's mucosa? | |||
---|---|---|---|
answered question | 42 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Yes | 64.3% | 27 | |
No | 35.7% | 15 |
3. Should patients with Barrett's esophagus undergo surveillance endoscopy periodically? | |||
---|---|---|---|
answered question | 42 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Yes | 100.0% | 42 | |
No | 0.0% | 0 |
4. When high grade dysplasia is identified in Barrett's mucosa, what is the likelihood that a patient will have invasive adenocarcinoma at that point in time? | |||
---|---|---|---|
answered question | 42 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
10% | 26.2% | 11 | |
20% | 26.2% | 11 | |
30% | 23.8% | 10 | |
40% or more | 23.8% | 10 |
5. If Barrett's high grade dysplasia is identified, check all tests or procedures you normally use for further evaluation at the time of diagnosis: | |||
---|---|---|---|
answered question | 42 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Repeat endoscopy (including any associated techniques such as chromoendoscopy, high resolution endoscopy, etc.) | 33.3% | 14 | |
CT scan | 14.3% | 6 | |
PET scan | 11.9% | 5 | |
EUS | 33.3% | 14 | |
EMR | 7.1% | 3 |
6. If Barrett's high grade dysplasia is confirmed and the patient is healthy, what do you most often recommend for initial management? | |||
---|---|---|---|
answered question | 42 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
Esophagectomy | 66.7% | 28 | |
EMR or other ablative procedure | 19.0% | 8 | |
Observation with close surveillance | 14.3% | 6 |
7. In what region is your surgical practice based? | |||
---|---|---|---|
answered question | 42 | ||
|
skipped question |
0
|
|
Response Percent |
Response Count |
||
North America | 61.9% | 26 | |
Europe | 26.2% | 11 | |
South America | 0.0% | 0 | |
Asia | 7.1% | 3 | |
Africa | 4.8% | 2 |